Probability of prostate cancer as a function of the percentage of free prostate-specific antigen in patients with a non-suspicious rectal examination and total prostate-specific antigen of 4–10 ng/ml

By Martínez-Piñeiro L.  

World Journal of Urology, Vol. 22, Iss. 2, 2004-06 ,pp. : 124-131

Springer Publishing Company

Access to resources Recommend Favorite

Post-treatment PSA =<0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniques - 5-year tumor control and morbidity

By Critz F.A.   Williams W.H.   Holladay C.T.   Levinson A.K.   Benton J.B.   Holladay D.A.   Schnell F.J.   Maxa L.S.   Shrake P.D.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 968-971

Elsevier

Access to resources Recommend Favorite

Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 ng/mL or less

By Yamamoto T.   Ito K.   Ohi M.   Kubota Y.   Suzuki K.   Fukabori Y.   Kurokawa K.   Yamanaka H.  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 994-998

Elsevier

Access to resources Recommend Favorite

Free/total PSA ratio can help in the prediction of high gleason score prostate cancer in men with total serum prostate specific antigen (PSA) of 3–10 ng/ml

By Elabbady Ahmed   Khedr Mahrousa  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 553-557

Springer Publishing Company

Access to resources Recommend Favorite

Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate cancer

By Benaim E.A.   Pace C.M.   Lam P.M.   Roehrborn C.G.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite